These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4999859)

  • 21. Acylureidoalkylphenylsulfonylureas with blood glucose lowering efficacy.
    Weyer R; Hitzel V
    Arzneimittelforschung; 1988 Aug; 38(8):1079-80. PubMed ID: 3196400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals.
    DeFronzo RA; Simonson DC
    Diabetes Care; 1984; 7 Suppl 1():72-80. PubMed ID: 6428844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probing of specific binding of synthetic sulfonylurea with the insulinoma cell line MIN6.
    Park KH; Akaike T
    J Biochem; 2005 Jul; 138(1):21-5. PubMed ID: 16046444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Synergism between oral diabetics and insulin].
    Consiglio D; Mantia G; Hopps V
    Boll Soc Ital Biol Sper; 1971 Nov; 47(22):737-42. PubMed ID: 5004485
    [No Abstract]   [Full Text] [Related]  

  • 25. Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride.
    Basu A; Charkoudian N; Schrage W; Rizza RA; Basu R; Joyner MJ
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1289-95. PubMed ID: 17711996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New oral antidiabetic drugs. 3.
    Ambrogi V; Bloch K; Daturi S; Logemann W; Parenti MA; Tommasini R
    Arzneimittelforschung; 1972 Mar; 22(3):542-4. PubMed ID: 5067927
    [No Abstract]   [Full Text] [Related]  

  • 27. [Influence of adrenergic receptor blockaders on the hypoglycemic action of glibenclamide].
    Hopps V; Mantia G; Leone F
    Boll Soc Ital Biol Sper; 1971 Nov; 47(21):733-6. PubMed ID: 4401856
    [No Abstract]   [Full Text] [Related]  

  • 28. [Glisolamide, a new sulfanylurea. Pharmacologic characteristics].
    D'Alò G; Dalla Vedova R; Cadel S; Campi G; Wassermann A
    Boll Chim Farm; 1978 Jun; 117(6):348-67. PubMed ID: 743381
    [No Abstract]   [Full Text] [Related]  

  • 29. Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes.
    Niemi M; Cascorbi I; Timm R; Kroemer HK; Neuvonen PJ; Kivistö KT
    Clin Pharmacol Ther; 2002 Sep; 72(3):326-32. PubMed ID: 12235454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interference of the sulphonylurea antidiabeticum gliquidone with mitochondrial bioenergetics in the rat under in vitro conditions.
    Somogyi J; Vér A; Trója G; Végh E; Bühler C; Hatfaludi F; Csermely P; Popović S
    Acta Physiol Hung; 1995; 83(4):299-312. PubMed ID: 8863893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukocytoclastic vasculitis induced by use of glyburide: a case of possible cross-reaction of a sulfonamide and a sulfonylurea.
    Bukhalo M; Zeitouni NC; Cheney RT
    Cutis; 2003 Mar; 71(3):235-8. PubMed ID: 12661752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.
    Desnoyers P; Labaume J; Anstett M; Herrera M; Pesquet J; Sebastien J
    Arzneimittelforschung; 1972 Oct; 22(10):1691-5. PubMed ID: 4677058
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.
    Francis M; Langhan T; Prosser J; Hoffman R
    Ann Emerg Med; 2008 Jun; 51(6):795-6; author reply 796-7. PubMed ID: 18489980
    [No Abstract]   [Full Text] [Related]  

  • 34. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
    Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
    Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoglycaemic effects of the novel antidiabetic agent repaglinide in rats and dogs.
    Mark M; Grell W
    Br J Pharmacol; 1997 Aug; 121(8):1597-604. PubMed ID: 9283692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New hypoglycemic benzenesulfonamido-pyrimidines N-substituted 4- N-(2-pyrimidinyl) sulfonyl--phenylacetamides].
    Gutsche K; Schröder E; Rufer C; Loge O
    Arzneimittelforschung; 1974 Jul; 24(7):1028-39. PubMed ID: 4408077
    [No Abstract]   [Full Text] [Related]  

  • 37. Investigation of the effects of sulfonylurea exposure on pancreatic beta cell metabolism.
    Brennan L; Hewage C; Malthouse JP; McClenaghan NH; Flatt PR; Newsholme P
    FEBS J; 2006 Nov; 273(22):5160-8. PubMed ID: 17054712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Derivatives of pyrazole-l-carboxylic acid. VII. Synthesis and hypoglycemic properties of various N-(4-[2-(alkyl-2-pyrazoline-1-carbonamido)-ethyl]-benzenesulfonyl)-N'-cyclohexylurea].
    Brzozowski Z; Magiełka S; Wójcikowski C
    Acta Pol Pharm; 1983; 40(2):134-8. PubMed ID: 6659996
    [No Abstract]   [Full Text] [Related]  

  • 39. Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients.
    Tseng CH; Huang TS
    Diabetes Res Clin Pract; 2005 Nov; 70(2):193-4. PubMed ID: 16188579
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacological interference of glibornuride with sulfaphenazole, phenylbutazone, and phenprocoumon in man].
    Eckhardt W; Rudolph R; Sauer H; Schubert WR; Undeutsch D
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2212. PubMed ID: 4679251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.